Abstract
Abstract
Alzheimer’s disease (AD) has become one of the most worrying health conditions with no effective treatment available with the increase in population aging. A large number of clinical studies and experiments proved that photobiomodulation (PBM) had a positive effect on AD treatment. The irradiation with red and near-infrared light at a low dose can effectively reduce an accumulation of amyloid-β (Aβ) plaques in the central nervous system, relieving the symptoms of AD. This review summarizes the parameters of PBM for AD treatment studied on cells, animals, and in clinical trials, as well as the dose–effect relationship of PBM treatment for AD. The mechanisms of PBM on the cellular level, which include regulation of microglia and astrocytes that may affect Aβ plaque elimination are also discussed.
Funder
Shenzhen Basic Research Project
Shenzhen International Cooperation Project
National Natural Science Foundation of China
Subject
Surfaces, Coatings and Films,Acoustics and Ultrasonics,Condensed Matter Physics,Electronic, Optical and Magnetic Materials
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献